tradingkey.logo

Helius Medical Technologies Inc

HSDT

6.000USD

-0.100-1.64%
Fechamento 08/04, 16:00ETCotações atrasadas em 15 min
49.01KValor de mercado
PerdaP/L TTM

Helius Medical Technologies Inc

6.000

-0.100-1.64%
Mais detalhes de Helius Medical Technologies Inc Empresa
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
Informações da empresa
Código da empresaHSDT
Nome da EmpresaHelius Medical Technologies Inc
Data de listagemJun 27, 2014
CEOMr. Dane C. Andreeff
Número de funcionários21
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 27
Endereço642 Newtown Yardley Road
CidadeNEWTOWN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal18940
Telefone12159446100
Sitehttps://heliusmedical.com/
Código da empresaHSDT
Data de listagemJun 27, 2014
CEOMr. Dane C. Andreeff
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Chairman of the Board
Independent Chairman of the Board
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Chairman of the Board
Independent Chairman of the Board
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Canada
19.00K
38.78%
United States
19.00K
38.78%
Other revenue
11.00K
22.45%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 12 de jul
Atualizado em: sáb, 12 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
L1 Capital Global Opportunities Master Fund Ltd.
0.63%
Heights Capital Management, Inc.
0.54%
Leonite Fund I LP
0.48%
Baader Bank AG
0.15%
Independent Financial Partners
0.02%
Other
98.18%
Investidores
Investidores
Proporção
L1 Capital Global Opportunities Master Fund Ltd.
0.63%
Heights Capital Management, Inc.
0.54%
Leonite Fund I LP
0.48%
Baader Bank AG
0.15%
Independent Financial Partners
0.02%
Other
98.18%
Tipos de investidores
Investidores
Proporção
Corporation
1.11%
Investment Advisor
0.54%
Investment Advisor/Hedge Fund
0.15%
Hedge Fund
0.03%
Family Office
0.02%
Other
98.14%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
37
12.50K
1.83%
+12.06K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
2023Q1
55
22.24K
15.26%
-34.89K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
L1 Capital Global Opportunities Master Fund Ltd.
4.28K
0.61%
+4.28K
--
Jun 06, 2025
Heights Capital Management, Inc.
3.67K
0.52%
+3.67K
--
Jun 04, 2025
Leonite Fund I LP
3.26K
0.47%
+3.26K
--
Jun 05, 2025
Independent Financial Partners
7.00
0%
--
--
Mar 31, 2025
Armistice Capital LLC
96.00
0.01%
+96.00
--
Mar 31, 2025
Geode Capital Management, L.L.C.
47.00
0.01%
+18.00
+62.07%
Mar 31, 2025
Maple Leaf Partners, L.P.
44.00
0.01%
-1.00
-2.22%
May 02, 2025
Citadel Advisors LLC
36.00
0.01%
+36.00
--
Mar 31, 2025
The Vanguard Group, Inc.
17.00
0%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Data
Tipo
Proporção
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Aug 16, 2023
Merger
50<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
Dec 31, 2020
Merger
35<1
KeyAI